within Pharmacolibrary.Drugs.ATC.G;

model G01AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Acetarsol (N-acetyl-4-hydroxy-m-arsanilic acid) is an organoarsenic compound previously used as an anti-infective agent, particularly in the treatment of protozoal infections such as trichomoniasis and amoebiasis. It is rarely used today and is not approved in many countries due to safety concerns regarding arsenic compounds.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult population, as no human PK studies with quantitative absorption, distribution or clearance data are available in published literature.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G01AB01;
